193 related articles for article (PubMed ID: 19254652)
1. Health care inequities: an introduction for dermatology providers.
Sauaia A; Dellavalle RP
Dermatol Clin; 2009 Apr; 27(2):103-7, v. PubMed ID: 19254652
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Association Between Social Determinants of Health and Receipt of Immunotherapy for Melanoma.
Ramirez F; Vasquez R; Gill J; Riva H; Zambrano A; Samaniego M; Fernandez L; Chacon J
J Drugs Dermatol; 2024 May; 23(5):311-315. PubMed ID: 38709695
[TBL] [Abstract][Full Text] [Related]
3. The impact of demographics, socioeconomics, and health care access on melanoma outcomes.
Cortez JL; Vasquez J; Wei ML
J Am Acad Dermatol; 2021 Jun; 84(6):1677-1683. PubMed ID: 32783908
[TBL] [Abstract][Full Text] [Related]
4. Short German guidelines: malignant melanoma.
Garbe C; Schadendorf D; Stolz W; Volkenandt M; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R; Hauschild A
J Dtsch Dermatol Ges; 2008 May; 6 Suppl 1():S9-S14. PubMed ID: 18801142
[No Abstract] [Full Text] [Related]
5. S3-guideline "diagnosis, therapy and follow-up of melanoma" -- short version.
Pflugfelder A; Kochs C; Blum A; Capellaro M; Czeschik C; Dettenborn T; Dill D; Dippel E; Eigentler T; Feyer P; Follmann M; Frerich B; Ganten MK; Gärtner J; Gutzmer R; Hassel J; Hauschild A; Hohenberger P; Hübner J; Kaatz M; Kleeberg UR; Kölbl O; Kortmann RD; Krause-Bergmann A; Kurschat P; Leiter U; Link H; Loquai C; Löser C; Mackensen A; Meier F; Mohr P; Möhrle M; Nashan D; Reske S; Rose C; Sander C; Satzger I; Schiller M; Schlemmer HP; Strittmatter G; Sunderkötter C; Swoboda L; Trefzer U; Voltz R; Vordermark D; Weichenthal M; Werner A; Wesselmann S; Weyergraf AJ; Wick W; Garbe C; Schadendorf D;
J Dtsch Dermatol Ges; 2013 Jun; 11(6):563-602. PubMed ID: 23721604
[No Abstract] [Full Text] [Related]
6. Barriers to Care-Seeking and Treatment Adherence Among Dermatology Patients: A Cross-Sectional National Survey Study.
Venkatesh K; Brito G; Nelson K; Friedman A
J Drugs Dermatol; 2022 Jun; 21(6):677-680. PubMed ID: 35674755
[TBL] [Abstract][Full Text] [Related]
7. Response to health inequity: the role of social protection in reducing poverty and achieving equity.
Scheil-Adlung X
Health Promot Int; 2014 Jun; 29 Suppl 1():i59-67. PubMed ID: 25217357
[TBL] [Abstract][Full Text] [Related]
8. Distance to diagnosing provider as a measure of access for patients with melanoma.
Stitzenberg KB; Thomas NE; Dalton K; Brier SE; Ollila DW; Berwick M; Mattingly D; Millikan RC
Arch Dermatol; 2007 Aug; 143(8):991-8. PubMed ID: 17709657
[TBL] [Abstract][Full Text] [Related]
9. Inequities in accessibility to and utilisation of maternal health services in Ghana after user-fee exemption: a descriptive study.
Ganle JK; Parker M; Fitzpatrick R; Otupiri E
Int J Equity Health; 2014 Nov; 13():89. PubMed ID: 25388288
[TBL] [Abstract][Full Text] [Related]
10. Is Access to Care Associated With Stage at Presentation and Survival for Melanoma Patients?
Pitre LD; Linford G; Pond GR; McWhirter E; Seow H
J Cutan Med Surg; 2019; 23(6):586-594. PubMed ID: 31462069
[TBL] [Abstract][Full Text] [Related]
11. Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification.
Follmann M; Schadendorf D; Kochs C; Buchberger B; Winter A; Wesselmann S
J Dtsch Dermatol Ges; 2014 Feb; 12(2):139-47. PubMed ID: 24238575
[TBL] [Abstract][Full Text] [Related]
12. Melanoma prognosis in the United States: Identifying barriers for improved care.
Hopkins ZH; Moreno C; Carlisle R; Secrest AM
J Am Acad Dermatol; 2019 May; 80(5):1256-1262. PubMed ID: 30659870
[TBL] [Abstract][Full Text] [Related]
13. Melanoma healthcare and outcome disparities.
Heymann WR
J Am Acad Dermatol; 2021 Jun; 84(6):1545-1546. PubMed ID: 33823200
[No Abstract] [Full Text] [Related]
14. How to navigate dermatology care for the uninsured.
Shwe S; Kassira S; Kim DJ; Elsensohn A; Lee P
J Am Acad Dermatol; 2019 Jun; 80(6):1809-1813. PubMed ID: 30114454
[No Abstract] [Full Text] [Related]
15. [How to reduce health inequities by targeting social determinants: the role of the health sector in Mexico].
Martínez Valle A; Terrazas P; Alvarez F
Rev Panam Salud Publica; 2014 Apr; 35(4):264-9. PubMed ID: 24870005
[TBL] [Abstract][Full Text] [Related]
16. Health inequity and social determinants of healthcare utilization in the disadvantaged community of Hong Kong.
Tan JHI; Goh AXC; Yi H
Health Promot Int; 2023 Aug; 38(4):. PubMed ID: 34897425
[TBL] [Abstract][Full Text] [Related]
17. Barriers to healthcare access in pediatric dermatology: A systematic review.
Toy J; Gregory A; Rehmus W
Pediatr Dermatol; 2021 Nov; 38 Suppl 2():13-19. PubMed ID: 34338358
[TBL] [Abstract][Full Text] [Related]
18. Racial and Ethnic Health Disparities in Dermatology.
Brown SG; Cobb CBC; Harvey VM
Dermatol Clin; 2023 Apr; 41(2):325-333. PubMed ID: 36933922
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Management of Malignant Melanoma in Store-and-Forward Teledermatology.
Wang M; Gendreau JL; Gemelas J; Capulong D; Lau C; Mata-Diaz S; Bratten DM; Dougall B; Markham C; Raugi GJ
Telemed J E Health; 2017 Nov; 23(11):877-880. PubMed ID: 28498031
[TBL] [Abstract][Full Text] [Related]
20. Health-care access as a social determinant of health.
McGibbon E; Etowa J; McPherson C
Can Nurse; 2008 Sep; 104(7):22-7. PubMed ID: 18856224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
